Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology

Cell Biology and Toxicology

Volumn 25, Issue 6, 2009, Pages 561-571

  Jeannesson, Elise ^a,b   Siest, Gérard ^a,b   Zaiou, Mohamed ^a,b   Berrahmoune, Hind ^a   Masson, Christine ^a,b   Visvikis Siest, Sophie ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Cardiovascular system; Cell lines; Genetic profiles; Pathophysiology; Pharmacotoxicology

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL ADHESION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; LIPID METABOLISM; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

APOLIPOPROTEIN E4; BLOOD PRESSURE; CACO-2 CELLS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL LINE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HEP G2 CELLS; HL-60 CELLS; HUMANS; INFLAMMATION; K562 CELLS; LIPID METABOLISM; MODELS, CARDIOVASCULAR; ORGAN SPECIFICITY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; U937 CELLS;

EID: 69049109843     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-008-9112-8     Document Type: Article

References (62)

1. CA Argmann JY Edwards CG Sawyez CH O'Neil RA Hegele JG Pickering MW Huff 2005 Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl- CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux J Biol Chem 280 23 22212 22221 10.1074/jbc.M502761200 15817453 doi:10.1074/jbc.M502761200 (Pubitemid 40827878)
2. N Barzilai G Atzmon C Schechter EJ Schaefer AL Cupples R Lipton S Cheng AR Shuldiner 2003 Unique lipoprotein phenotype and genotype associated with exceptional longevity JAMA 290 15 2030 2040 10.1001/jama.290.15.2030 14559957 doi:10.1001/jama.290.15.2030 (Pubitemid 37430586)
3. B Baudin 2002 Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations Pharmacogenomics 3 1 65 73 10.1517/14622416.3.1. 65 11966404 doi:10.1517/14622416.3.1.65 (Pubitemid 34285240)
4. JL Benton J Ding MY Tsai S Shea JI Rotter GL Burke W Post 2007 Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 193 2 352 360 10.1016/j.atherosclerosis.2006.06.024 16879828 doi:10.1016/j.atherosclerosis.2006.06.024 (Pubitemid 47058097)
5. F Brahimi P Bertrand M Starck MM Galteau G Siest 2001 Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2 Cell Biochem Funct 19 1 51 58 10.1002/cbf.899 11223871 doi:10.1002/cbf.899 (Pubitemid 32178745)
6. EF Brandon TM Bosch MJ Deenen R Levink E van der Wal JB van Meerveld M Bijl JH Beijnen JH Schellens I Meijerman 2006 Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines Toxicol Appl Pharmacol 211 1 1 10 10.1016/j.taap.2005.05.004 15975613 doi:10.1016/j.taap.2005.05.004 (Pubitemid 43152092)
7. E Capoluongo D Pitocco P Concolino C Santonocito E Di Stasio G d'Onofrio A Manto B Giardina G Ghirlanda F Ameglio C Zuppi 2006 Slight association between type 1 diabetes and "ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications Clin Biochem 39 9 888 892 10.1016/j.clinbiochem.2006.05.006 16806146 doi:10.1016/j.clinbiochem.2006.05.006 (Pubitemid 44344686)
8. DI Chasman D Posada L Subrahmanyan NR Cook VP Stanton Jr PM Ridker 2004 Pharmacogenetic study of statin therapy and cholesterol reduction JAMA 291 23 2821 2827 10.1001/jama.291.23.2821 15199031 doi:10.1001/jama.291.23.2821 (Pubitemid 38747801)
9. S Cheng C Pallaud MA Grow SJ Scharf HA Erlich W Klitz CR Pullinger MJ Malloy JP Kane G Siest S Visvikis 1998 A multilocus genotyping assay for cardiovascular disease Clin Chem Lab Med 36 8 561 566 10.1515/CCLM.1998.096 9806460 doi:10.1515/CCLM.1998.096 (Pubitemid 28468305)
10. S Cheng MA Grow C Pallaud W Klitz HA Erlich S Visvikis JJ Chen CR Pullinger MJ Malloy G Siest JP Kane 1999 A multilocus genotyping assay for candidate markers of cardiovascular disease risk Genome Res 9 10 936 949 10.1101/gr.9.10.936 10523522 doi:10.1101/gr.9.10.936 (Pubitemid 29525202)
11. J Dallongeville N Helbecque D Cottel P Amouyel A Meirhaeghe 2003 The Gly16->Arg16 and Gln27->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men J Clin Endocrinol Metab 88 10 4862 4866 10.1210/jc.2003-030173 14557466 doi:10.1210/jc.2003-030173 (Pubitemid 37361095)
12. EM Fach LA Garulacan J Gao Q Xiao SM Storm YP Dubaquie SA Hefta GJ Opiteck 2004 In vitro biomarker discovery for atherosclerosis by proteomics Mol Cell Proteomics 3 12 1200 1210 10.1074/mcp.M400160-MCP200 15496433 doi:10.1074/mcp.M400160-MCP200
13. M Fiegenbaum FR da Silveira CR Van der Sand LC Van der Sand ME Ferreira RC Pires MH Hutz 2005 The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment Clin Pharmacol Ther 78 5 551 558 10.1016/j.clpt.2005.08.003 16321621 doi:10.1016/j.clpt.2005.08.003 (Pubitemid 41698910)
14. A Flex E Gaetani P Papaleo G Straface AS Proia G Pecorini P Tondi P Pola R Pola 2004 Proinflammatory genetic profiles in subjects with history of ischemic stroke Stroke 35 10 2270 2275 10.1161/01.STR.0000140740.19421.fe 15308783 doi:10.1161/01.STR.0000140740.19421.fe (Pubitemid 39311248)
15. A Garrigues AE Escargueil S Orlowski 2002 The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane Proc Natl Acad Sci U S A 99 16 10347 10352 10.1073/pnas.162366399 12145328 doi:10.1073/pnas.162366399 (Pubitemid 34906979)
16. AP Gjesing G Andersen KS Burgdorf K Borch-Johnsen T Jorgensen T Hansen O Pedersen 2007 Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects Diabetologia 50 3 563 568 10.1007/s00125-006-0578-8 17221209 doi:10.1007/s00125-006-0578-8 (Pubitemid 46215499)
17. YH Hamid CS Rose SA Urhammer C Glumer R Nolsoe OP Kristiansen T Mandrup-Poulsen K Borch-Johnsen T Jorgensen T Hansen O Pedersen 2005 Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes Diabetologia 48 2 251 260 10.1007/s00125-004-1623-0 15645209 doi:10.1007/s00125-004-1623-0 (Pubitemid 40543296)
18. C Hoppe S Cheng M Grow A Silbergleit W Klitz E Trachtenberg H Erlich E Vichinsky L Styles 2001 A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia Br J Haematol 114 3 718 720 10.1046/j.1365-2141.2001.02997.x 11553004 doi:10.1046/j.1365-2141.2001.02997.x (Pubitemid 32953657)
19. C Hoppe W Klitz S Cheng R Apple L Steiner L Robles T Girard E Vichinsky L Styles 2004 Gene interactions and stroke risk in children with sickle cell anemia Blood 103 6 2391 2396 10.1182/blood-2003-09-3015 14615367 doi:10.1182/blood-2003-09-3015 (Pubitemid 38326263)
20. JA Hubacek KE Berge J Stefkova J Pitha Z Skodova V Lanska R Poledne 2004 Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels Physiol Res 53 4 395 401 15311998
21. Hughes P, Marshall D, Reid Y, Parkes H and Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? BioTechniques 2007;43(5):575,57 577-578, 58581-2 passim.
22. SE Humphries LA Luong MS Ogg E Hawe GJ Miller 2001 The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur Heart J 22 24 2243 2252 10.1053/euhj.2001.2678 11728144 doi:10.1053/euhj.2001.2678 (Pubitemid 34000979)
23. N Iwamoto S Abe-Dohmae M Ayaori N Tanaka M Kusuhara F Ohsuzu S Yokoyama 2007 ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-adrenoceptor blockade Circ Res 101 2 156 165 10.1161/CIRCRESAHA.107.151746 17556657 doi:10.1161/CIRCRESAHA.107.151746 (Pubitemid 47196583)
24. H Jakubowski 2006 Pathophysiological consequences of homocysteine excess J Nutr 136 Suppl 6 1741S 1749S 16702349
25. E Jeannesson L Albertini G Siest AM Gomes V Ribeiro C Aslanidis G Schmitz S Visvikis-Siest 2007 Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population Fundam Clin Pharmacol 21 4 411 418 10.1111/j.1472-8206.2007.00507.x 17635180 doi:10.1111/j.1472-8206.2007.00507.x (Pubitemid 47084031)
26. MK Jensen JK Pai KJ Mukamal K Overvad EB Rimm 2007 Common genetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk of coronary heart disease Atherosclerosis 195 1 e172 80 10.1016/j.atherosclerosis. 2007.01.025 17368464 doi:10.1016/j.atherosclerosis.2007.01.025 (Pubitemid 47561955)
27. KL Klos CF Sing E Boerwinkle SC Hamon TJ Rea A Clark M Fornage JE Hixson 2006 Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants Arterioscler Thromb Vasc Biol 26 8 1828 1836 10.1161/01.ATV.0000231523.19199.45 16763159 doi:10.1161/01.ATV.0000231523.19199.45 (Pubitemid 44305337)
28. H Knoblauch A Bauerfeind MR Toliat C Becker T Luganskaja UP Gunther K Rohde H Schuster C Junghans FC Luft P Nurnberg JG Reich 2004 Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol Hum Mol Genet 13 10 993 1004 10.1093/hmg/ddh119 15044381 doi:10.1093/hmg/ddh119 (Pubitemid 38702186)
29. Y Kokubo H Tomoike C Tanaka M Banno T Okuda N Inamoto K Kamide Y Kawano T Miyata 2006 Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension Hypertens Res 29 8 611 619 10.1291/hypres.29.611 17137217 doi:10.1291/hypres.29. 611 (Pubitemid 44430470)
30. CQ Lai LD Parnell JM Ordovas 2005 The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk Curr Opin Lipidol 16 2 153 166 10.1097/01.mol.0000162320.54795.68 15767855 doi:10.1097/01.mol.0000162320.54795. 68
31. K Lenaerts FG Bouwman WH Lamers J Renes EC Mariman 2007 Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium BMC Genomics 8 91 10.1186/1471-2164-8-91 17407598 doi:10.1186/1471-2164-8-91 (Pubitemid 46614506)
32. JC Liang Y Ning RY Wang HM Padilla-Nash E Schrock D Soenksen L Nagarajan T Ried 1999 Spectral karyotypic study of the HL-60 cell line: detection of complex rearrangements involving chromosomes 5, 7, and 16 and delineation of critical region of deletion on 5q31.1 Cancer Genet Cytogenet 113 2 105 109 10.1016/S0165-4608(99)00030-8 10484974 doi:10.1016/S0165-4608(99)00030-8 (Pubitemid 29381544)
33. T Maejima H Yamazaki T Aoki T Tamaki F Sato M Kitahara Y Saito 2004 Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell Biochem Biophys Res Commun 324 2 835 839 10.1016/j.bbrc.2004.09.122 15474503 doi:10.1016/j.bbrc.2004.09.122 (Pubitemid 39345591)
34. AH Maitland-van der Zee BH Stricker OH Klungel AK Mantel-Teeuwisse JJ Kastelein A Hofman HG Leufkens CM van Duijn A de Boer 2003 Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes Pharmacogenetics 13 4 219 223 10.1097/00008571-200304000-00006 12668918 doi:10.1097/00008571-200304000-00006 (Pubitemid 36543394)
35. G Marti L Audi C Esteban M Oyarzabal M Chueca M Gussinye D Yeste M Fernandez-Cancio P Andaluz A Carrascosa 2004 Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus in two Spanish populations Med Clin (Barc) 123 8 286 290
36. C Marzolini E Paus T Buclin RB Kim 2004 Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance Clin Pharmacol Ther 75 1 13 33 10.1016/j.clpt.2003.09.012 14749689 doi:10.1016/j.clpt.2003.09.012 (Pubitemid 38130115)
37. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 3 1215 10.1093/nar/16.3.1215 3344216 doi:10.1093/nar/16.3.1215
38. F Nagai Y Hiyoshi K Sugimachi HO Tamura 2002 Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines Biol Pharm Bull 25 3 383 385 10.1248/bpb.25.383 11913539 doi:10.1248/bpb.25.383 (Pubitemid 39663295)
39. D Namgaladze B Brune 2006 Phospholipase A2-modified low-density lipoprotein activates the phosphatidylinositol 3-kinase-Akt pathway and increases cell survival in monocytic cells Arterioscler Thromb Vasc Biol 26 11 2510 2516 10.1161/01.ATV.0000245797.76062.2e 16973971 doi:10.1161/01.ATV. 0000245797.76062.2e (Pubitemid 44607473)
40. JC Ongagna M Pinget A Belcourt 2005 Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes Clin Biochem 38 5 415 419 10.1016/j.clinbiochem.2004.12.013 15820770 doi:10.1016/j.clinbiochem.2004.12.013
41. JF Oram JW Heinecke 2005 ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease Physiol Rev 85 4 1343 1372 10.1152/physrev.00005.2005 16183915 doi:10.1152/physrev.00005.2005 (Pubitemid 41362273)
42. K Ozaki Y Ohnishi A Iida A Sekine R Yamada T Tsunoda H Sato H Sato M Hori Y Nakamura T Tanaka 2002 Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction Nat Genet 32 4 650 654 10.1038/ng1047 12426569 doi:10.1038/ng1047 (Pubitemid 35435179)
43. JK Pai P Kraft CC Cannuscio JE Manson KM Rexrode CM Albert D Hunter EB Rimm 2006 Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women Atherosclerosis 186 1 132 139 10.1016/j.atherosclerosis.2005.06.041 16055130 doi:10.1016/j. atherosclerosis.2005.06.041
44. C Pallaud R Gueguen C Sass M Grow S Cheng G Siest S Visvikis 2001 Genetic influences on lipid metabolism trait variability within the Stanislas Cohort J Lipid Res 42 11 1879 1890 11714857
45. S Riou B Mees B Esposito R Merval J Vilar D Stengel E Ninio R van Haperen R de Crom A Tedgui S Lehoux 2007 High pressure promotes monocyte adhesion to the vascular wall Circ Res 100 8 1226 1233 10.1161/01.RES.0000265231.59354.2c 17395876 doi:10.1161/01.RES.0000265231.59354.2c (Pubitemid 46684136)
46. MA Rumi H Sato S Ishihara K Kawashima S Hamamoto H Kazumori T Okuyama R Fukuda N Nagasue Y Kinoshita 2001 Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma Br J Cancer 84 12 1640 1647 10.1054/bjoc.2001.1821 11401318 doi:10.1054/bjoc.2001. 1821 (Pubitemid 32612496)
47. G Schmitz T Langmann 2006 Pharmacogenomics of cholesterol-lowering therapy Vascul Pharmacol 44 2 75 89 10.1016/j.vph.2005.07.012 16337220 doi:10.1016/j.vph.2005.07.012 (Pubitemid 43082209)
48. MY Shiau CY Wu CN Huang SW Hu SJ Lin YH Chang 2003 TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients Tissue Antigens 61 5 393 397 10.1034/j.1399-0039.2003.00059.x 12753658 doi:10.1034/j.1399-0039. 2003.00059.x (Pubitemid 36605672)
49. MP Sie AG Uitterlinden MJ Bos PP Arp MM Breteler PJ Koudstaal HA Pols A Hofman CM van Duijn JC Witteman 2006 TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study Stroke 37 11 2667 2671 10.1161/01.STR.0000244779.30070.1a 17023672 doi:10.1161/01.STR.0000244779.30070. 1a (Pubitemid 44922523)
50. J Sun H Huang YY Zhu JP Lan JY Li XY Lai J Yu 2005 Study on the expression and mutation of human telomeric repeat binding factor (hTRF1) in 10 malignant hematopoietic cell lines J Zhejiang Univ Sci B 6 12 1141 1147 10.1631/jzus.2005.B1141 16358369 doi:10.1631/jzus.2005.B1141
51. JF Thompson ME Lira LK Durham RW Clark MJ Bamberger PM Milos 2003 Polymorphisms in the CETP gene and association with CETP mass and HDL levels Atherosclerosis 167 2 195 204 10.1016/S0021-9150(03)00005-4 12818401 doi:10.1016/S0021-9150(03)00005-4 (Pubitemid 36773520)
52. JF Thompson M Man KJ Johnson LS Wood ME Lira DB Lloyd P Banerjee PM Milos SP Myrand J Paulauskis MA Milad WJ Sasiela 2005 An association study of 43 SNPs in 16 candidate genes with atorvastatin response Pharmacogenomics J 5 6 352 358 10.1038/sj.tpj.6500328 16103896 doi:10.1038/sj.tpj.6500328
53. S Trompet D Pons AJ De Craen P Slagboom J Shepherd GJ Blauw MB Murphy SM Cobbe EL Bollen BM Buckley I Ford M Hyland A Gaw PW Macfarlane CJ Packard J Norrie IJ Perry DJ Stott BJ Sweeney C Twomey RG Westendorp JW Jukema 2007 Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study Ann NY Acad Sci 1100 189 198 10.1196/annals.1395.018 17460178 doi:10.1196/annals.1395.018 (Pubitemid 47092652)
54. FM van 't Hooft SJ von Bahr A Silveira A Iliadou P Eriksson A Hamsten 1999 Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration Arterioscler Thromb Vasc Biol 19 12 3063 3070 10591688 (Pubitemid 30029837)
55. C Verstuyft S Strabach H El-Morabet R Kerb U Brinkmann L Dubert P Jaillon C Funck-Brentano G Trugnan L Becquemont 2003 Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition Clin Pharmacol Ther 73 1 51 60 10.1067/mcp.2003.8 12545143 doi:10.1067/mcp.2003.8 (Pubitemid 36158486)
56. SV Vormfelde D Sehrt MR Toliat M Schirmer I Meineke M Tzvetkov P Nurnberg J Brockmoller 2007 Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs Clin Pharmacol Ther 82 3 300 309 10.1038/sj.clpt.6100131 17460608 doi:10.1038/sj.clpt.6100131 (Pubitemid 47260543)
57. LS Weinstein M Chen T Xie J Liu 2006 Genetic diseases associated with heterotrimeric G proteins Trends Pharmacol Sci 27 5 260 266 10.1016/j.tips.2006. 03.005 16600389 doi:10.1016/j.tips.2006.03.005
58. SL Wenger JR Senft LM Sargent R Bamezai N Bairwa SG Grant 2004 Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization Biosci Rep 24 6 631 639 10.1007/s10540-005-2797-5 16158200 doi:10.1007/s10540-005-2797-5 (Pubitemid 41297983)
59. CF Xu P Talmud H Schuster R Houlston G Miller S Humphries 1994 Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia Clin Genet 46 6 385 397 7889654
60. YL Yu ZY Huang PY Yang YC Rui 2003 Proteomic studies of macrophage-derived foam cell from human U937 cell line using two-dimensional gel electrophoresis and tandem mass spectrometry J Cardiovasc Pharmacol 42 6 782 789 10.1097/00005344-200312000-00013 14639101 doi:10.1097/00005344-200312000- 00013 (Pubitemid 37467101)
61. RY Zee NR Cook S Cheng R Reynolds HA Erlich K Lindpaintner PM Ridker 2004 Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis Hum Mol Genet 13 4 389 396 10.1093/hmg/ddh039 14681304 doi:10.1093/hmg/ddh039 (Pubitemid 38239790)
62. T Zemunik V Skrabic V Boraska D Diklic IM Terzic V Capkun M Peruzovic J Terzic 2005 FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population J Mol Diagn 7 5 600 604 16258158